Skip to content
Home/Companies/Biotech/TargED Biopharmaceuticals

TargED Biopharmaceuticals

Biotech·Netherlands·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns TargED Biopharmaceuticals?

TargED Biopharmaceuticals is a Dutch Biotech company, currently owned by Sunstone Life Science Ventures since 2022.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Sunstone Life Science Ventures
Investor
Sunstone Life Science Ventures
Sunstone Life Science Ventures V · 2021 · VC

Key facts

HQNetherlands
SectorBiotech
StatusActive

More from Sunstone Life Science Ventures V

Other portfolio companies in the same fund.

Resalis Therapeutics
Resalis Therapeutics
Active
BiotechItaly· 2024
Diogenx
Active
BiotechFrance· 2023
Kynexis
Kynexis
Active
BiotechNetherlands· 2023
Rewind Therapeutics
Active
BiotechBelgium· 2023
Teitur Trophics
Active
BiotechDenmark· 2023
Cardior Pharmaceuticals
Exited 2024
BiotechGermany· 2021
to Novo Nordisk

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns TargED Biopharmaceuticals?

TargED Biopharmaceuticals is currently owned by Sunstone Life Science Ventures, through Sunstone Life Science Ventures V, since 2022.

When did Sunstone Life Science Ventures acquire TargED Biopharmaceuticals?

Sunstone Life Science Ventures acquired TargED Biopharmaceuticals in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue